| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 43.429 | 40.067 | 34.546 | 22.436 | 13.280 | 11.379 | 13.981 | 12.453 | 809 | 0 |
| Total Income - EUR | 43.429 | 40.067 | 34.546 | 22.436 | 13.280 | 11.379 | 13.981 | 12.453 | 809 | 0 |
| Total Expenses - EUR | 30.577 | 36.903 | 30.562 | 22.651 | 22.899 | 15.936 | 14.515 | 14.172 | 581 | 578 |
| Gross Profit/Loss - EUR | 12.852 | 3.164 | 3.984 | -216 | -9.619 | -4.557 | -534 | -1.719 | 227 | -578 |
| Net Profit/Loss - EUR | 11.549 | 2.763 | 3.644 | -440 | -9.752 | -4.667 | -674 | -1.828 | 203 | -578 |
| Employees | 1 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Elamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 71.513 | 68.135 | 66.752 | 62.876 | 59.637 | 57.096 | 54.691 | 13.385 | 12.763 | 12.114 |
| Current Assets | 749 | 105 | 694 | 477 | 356 | 1.019 | 613 | 0 | 809 | 804 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 524 | 43 | 0 | 0 | 271 | 266 | 55 | 0 | 0 | 0 |
| Cash | 225 | 62 | 694 | 477 | 85 | 753 | 558 | 0 | 809 | 804 |
| Shareholders Funds | 57.904 | 60.077 | 62.705 | 61.114 | 50.179 | 44.561 | 42.899 | 13.385 | 13.548 | 12.894 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 14.358 | 8.163 | 4.740 | 2.239 | 9.814 | 13.554 | 12.405 | 0 | 24 | 24 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Elamed S.r.l.